OSLO, NORWAY--(Marketwired - May 15, 2013) -
Algeta ASA (
New dates are as follows:
2(nd) Quarter Results 2013: 28 August 2013
3(rd) Quarter Results 2013: 6 November 2013
All dates are tentative and could be subject to change.
Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (ALGETA.OL). For more information please visit www.algeta.com.
Press release: http://hugin.info/134655/R/1701819/562060.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE